Comment on

• A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma.

  Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/Latanoprost Study Group. Noecker RS, et al. Am J Ophthalmol. 2003 Jan;135(1):55-63. doi: 10.1016/s0002-9394(02)01827-5. Am J Ophthalmol. 2003. PMID: 12504698 Clinical Trial.
• A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.

  Parrish RK, Palmberg P, Sheu WP; XLT Study Group. Parrish RK, et al. Am J Ophthalmol. 2003 May;135(5):688-703. doi: 10.1016/s0002-9394(03)00098-9. Am J Ophthalmol. 2003. PMID: 12719078 Clinical Trial.